Surviving Colon Cancer with Ivermectin - Dr Justus Hope
My friend Evan was given 12 months to live, given the average survival of someone with GBM.
However, patients who have added repurposed drug cocktails have far exceeded this, with multiple documented survivals of more than five, ten, and even twenty years. For example, Dr. Ben Willams has survived his GBM for 28 years by successfully adding repurposed drug cocktails. Thus, I wrote a book on repurposed drugs, Evan used the information, and he is still alive and thriving nearly four years later.
Now we turn to colon cancer. The standard of care involves highly toxic chemotherapy, surgery, and radiation. Yet the 5-year survival is only about 15%. Consider that the chemotherapy usually is FOLFOX, a cocktail involving three drugs, 5-fluorouracil (5-FU)- affectionately known as five feet under, leucovorin (LV), and oxaliplatin.
This treatment is the same as it has been for 20 years; it is outdated and barbaric, and certainly, our modern science offers much less toxic and more effective options. Common sense should tell you that all science has rocketed forward light years these past two decades, and our best and brightest medical minds can do much better than a 15% survival rate in 2023.
However, using these solutions to save hundreds of thousands of patients from cancer each year, I would argue, is possible, but not nearly as profitable for Big Pharma and their brethren. Thus, these options remain suppressed. Almost one million people die from colon cancer worldwide annually, according to ChatGPT. The annual overall cost of cancer care in the United States alone is $183 billion. ChatGPT notes that a substantial portion of this overall cost is related to colon cancer treatment.
Moreover, the toxicity of such chemotherapy adds to the profitability in a perverse way - because by creating bone marrow suppression, there is the need for further expensive hospitalization from resulting infections, related treatments including IV antibiotics, platelet and blood transfusions, and as I will later highlight, even resuscitation from myocardial infarction and cardiac arrest.
As you might suspect, adding safe and non-toxic repurposed drugs can EXPONENTIALLY improve one’s chances of survival, but this secret is seldom told to anyone. Those few lucky patients who find out sometimes try to spread the word, but Big Pharma, the mainstream media, and the medical establishment swiftly drown it out. If you doubt this, try looking up long-term survivors of pancreatic cancer and glioblastoma. Chances are you will see neither Dr. Ben Williams nor Dr. Steven Bigelsen’s names. Both used repurposed drugs to beat their cancers, one pancreatic and the other GBM.
And let me caution you that AI, particularly ChatGPT, is closely aligned with Big Pharma’s position on repurposed drugs and cancer; it will not mention the Care Oncology Clinic’s success in helping many patients achieve longer survival times.
My friend Evan credits much of his success to their protocol. But unfortunately, fewer than 2% of glioblastoma patients survive more than three years, and one must logically ask why he has survived. And the answer is that he chose to do something different than the standard of care, which on average produces a survival of only 12.7 months. Evan decided to add a repurposed drug combination which has been the common denominator of survival in almost all the success stories I have covered.
Now my friend Abe is facing advanced colon cancer including surgery to remove the tumor. FOLFOX, the three-drug combination with side effects including neuropathy, hair loss, low platelets, anemia, and liver failure, will probably follow this. Additionally, will be radiation treatment, a medical bill averaging up to ten thousand dollars per month, and an 85% chance of death within five years.
I don’t know about you, but if I were dealing with advanced colon cancer, I would not be satisfied with the standard toxic treatment plan and its abysmal outcome rates. So instead, I would try to improve my chances. And I would start by looking at what other long-term cancer survivors did that worked. And I would follow that up with PubMed studies published by non-captured scientists in non-captured medical journals.
The results of using Ivermectin in cancer are extraordinary. Considering that Ivermectin has none of the toxic side effects of FOLFOX, let us examine Rick’s experience.
Rick and his wife, Eve, were interviewed by an intrepid young man whose YouTube channel is known as The Cancer Box. Rick, a Port Angeles, Washington resident, worked the sawmill most of his life and retired at 62 in 2019 to live the good life with Eve.
Unfortunately, he noticed a change in bowel habits, and after being told to eat more fiber and drink more water, Rick insisted on a Colonoscopy. Unfortunately, this study revealed a large, advanced colon cancer. Rick, not a usual visitor to doctors, reluctantly saw the Oncologist. He and his wife explain that the good doctor did not even look up from his computer screen while delivering the prognosis. “Your cancer is not survivable,” he proclaimed.
With this news, Rick sat stunned while his wife began sobbing. The couple exited the good doctor’s office more determined than ever to fight the cancer. They drew strength from their faith in God. Following a new referral to another Oncologist, they were once again informed of the grim prognosis. The cancer specialist estimated he had maybe six months to live and did not advise either surgery or radiation due to the advanced stage [10:05].
The cancer had spread throughout his lymph nodes, and he had 20 metastases in his liver.
However, Rick and Eve decided upon a course of radiation. Still, they noted the tumor marker CEA, the carcinoembryonic antigen, an indicator of tumor activity, was elevated in the 480 range as of November 2020. He was given ten courses of radiation, yet the CEA tumor marker level continued to rise. He changed Oncologists and started chemotherapy on December 31, 2020. His CEA had risen to 1498. Eve notes that this number was off the charts, as they “did not go that high” [11:09].
Rick and Eve then discovered Ivermectin and noticed that it was not only safe, but studies have shown it to enhance the effectiveness of chemotherapy and radiation. So, on his birthday, February 2, 2021, Rick took his first dose of Ivermectin.
By February 10, 2021, his CEA had plummeted to 184. By March 10, the number was 47.9. By April 7, it was 20.7; by April 21, it had dropped to 13.9. By July, it had fallen to 4.7, and Rick then enjoyed remission. Rick was quick to add that the adverse effects of the chemotherapy were so severe, with the neuropathy, the facial skin pealing, and the allergic reactions, that it was placed on multiple holds; however, he faithfully continued the Ivermectin at a dose of approximately 18 mg per two weeks, and with his oncologist’s blessing.
Following the plunge in CEA levels, other evidence appeared of the tumor’s reduction. CT scanning failed to show proof of lymph node involvement, and the liver metastases shrunk and calcified. His cancer treatment team felt his improvement was nothing short of miraculous.
Unfortunately, due to his chemotherapy, he sustained a cardiac arrest and myocardial infarction in June 2021 [18:03].
As a result, his chemotherapy was held until August; however, Ivermectin continued despite his pharmacy threatening not to fill it due to the political COVID-19 controversy. Finally, when his physician clarified he was taking the drug for cancer, the pharmacy relented.
Recent studies have strongly supported Ivermectin’s potential benefit in colon cancer. Jiang and colleagues found that Ivermectin has a strong anti-metastasis effect. It does so by inhibiting multiple pathways, including WnT, which I discuss further in my book on repurposed cancer drugs. It also inhibits Beta1/FAK expression.
In another study, Jiang found that Ivermectin drastically reversed drug resistance of the colon tumor cells to chemotherapy both in vitro and in vivo. Zhou independently found that Ivermectin induced colon cancer cell apoptosis, and inhibited cancer cell growth.
What can we learn from the overall experience of repurposed drug use in cancer? First, it appears that at least anecdotally patients are more likely to survive typically “unsurvivable” cancers if they add them. Second, there does not seem to be a downside, as repurposed drugs have been proven safe for millions in many other medical conditions. Third, it behooves a cancer patient to obtain multiple oncology second opinions, as the advice of even one or two cancer specialists may not offer the best chances for survival. Finally, it is buyer beware when consuming medical treatment in the United States as conventional cancer care is lucrative. As always, never take repurposed drugs without a valid prescription under the care of your personal physician.
It is not the medical doctors that are corrupted so much, as the fabric of the medical establishment prefers expensive and toxic cancer treatments over cheaper and safer repurposed drug combinations. Doctors generally are well-motivated people who genuinely desire to help suffering patients. They, however, have been taught - indoctrinated - in medical schools heavily influenced by Big Pharma. Therefore, it is up to you and me to open the eyes of our loved ones afflicted with cancer to adding repurposed drugs as early as possible in conjunction with the standard treatment of surgery, radiation, or chemotherapy. The Care Oncology Clinic, which does telemedicine service, can work in concert with your oncology team, and they are worth consulting at the time of cancer diagnosis. Their addition can mean the difference between life and death in my experience.
Cancer shares much in common with mutating viruses. And that is this. When confronted with a vaccine, a mutable virus evolves into a resistant version and then becomes even harder to kill. Thus, a multi-drug approach is essential to block the virus or cancer from rewiring itself into a more resistant form.
In an advanced cancer, when the tumor tree is attacked, signals are sent via the three major communication systems, the Notch, the WnT, and the Hedgehog, to the root system, the cancer stem cells. Unfortunately, during the period of remission, if given the chance, the tumor is busy reconstituting itself from these stimulated stem cells, and it is capable of later emerging into a fully constituted form. This occurs most of the time, in my experience, and is responsible for the failure of treatments that lack the addition of repurposed drug cocktails which are capable of preventing this.
Therefore, both cancers and mutable viruses can be successfully controlled and even eradicated with the cocktail approach.Former NIH scientist and Harvard Medical School Professor Dr. George Fareed began the first Imperial Valley AIDS Treatment Clinic some three decades ago in Brawley, California, and he still treats many of the same patients today who have survived AIDS thanks to his multi-drug cocktail approach. Dr. George Fareed and his associate, Dr. Brian Tyson, are now living legends in Imperial Valley, California. They saved more than 10,000 patients from the COVID-19 virus using a multi-drug cocktail that included Ivermectin and their story has been heard around the world.
Dr. Ben Willams contracted Glioblastoma Multiforme some 28 years ago, and he successfully treated himself with a cocktail of repurposed drugs and he remains alive today to write and speak about it. Dr. Steven Bigelsen did much the same and remains alive some five years after his diagnosis of Stage 4 pancreatic cancer. And my friend and colleague Evan, for whom I dedicated my book on repurposed drugs for cancer remains alive and well nearly four years following his diagnosis of Glioblastoma.
Repurposed multi-drug cocktails targeting cancer stem cells must be utilized from the outset. This method can permanently eradicate cancers and ensure long-term survival. This precious information must be shared by word-of-mouth, articles, and books as it never will appear in the mainstream media or captured medical journals.
About the Author: Dr. Justus R. Hope, writer’s pseudonym, graduated summa cum laude from Wabash College where he was named a Lilly Scholar. He attended Baylor College of Medicine where he was awarded the M.D. degree. He completed a residency in Physical Medicine & Rehabilitation at The University of California Irvine Medical Center. He is board-certified and has taught at The University of California Davis Medical Center in the departments of Family Practice and Physical Medicine & Rehabilitation. He has practiced medicine for over 35 years and maintains a private practice in Northern California.
.png)
Comments
Post a Comment